Search Results - R. V. Drai

Optimization of the Fc-fusion protein refolding method produced from the bacterial expression system by P. S. Astrelina, S. A. Ishchuk, A. V. Kabanova, R. V. Drai

Get full text

Quality Management in Pharmaceutical Development of Biotechnology-Derived Medicinal Products: Implementation and Evaluation by I. S. Giba, K. R. Salieva, A. A. Batueva, I. V. Grigorieva, R. V. Drai

Get full text

Experimental Validation of an <i>In Vitro</i> Method for Assessing Insulin-Dependent Glucose Uptake by A. N. Afanasyeva, V. B. Saparova, I. E. Makarenko, R. V. Drai, T. A. Selmenskikh

Get full text

Results of the Estimation of Biosimilarity of RinLiz^® (LLC «GEROPHARM», Russia) and Humalog^® (Lilly France, France) Using the Method of the Hyperinsulinemic E... by A. Yu. Mayorov, I. A. Fedotov, R. V. Drai, O. I. Avdeeva, I. E. Makarenko

Get full text

Optimisation of induction conditions for a bacterial strain producing proinsulin aspart by I. A. Kornakov, Z. R. Khasanshina, D. A. Senichkina, A. A. Filipenko, I. S. Lunev, R. V. Drai

Get full text

Experimental Validation a Method for Assessing Neutralizing Antibodies of Romiplostim in Human Plasma by A. N. Afanaseva, V. B. Saparova, I. E. Makarenko, T. A. Selmenskikh, D. V. Kurkin, A. L. Hohlov, R. V. Drai

Get full text

Physicochemical and Functional Characterization of Medicinal Product Rinsulin® R by A. V. Babina, R. V. Drai, V. B. Saparova, A. N. Afanasyeva, P. G. Zaikin, V. I. Shmurak, T. E. Eltysheva, I. E. Makarenko

Get full text

An Open-label Randomized Crossover Study with Adaptive Design of the Pharmacokinetics and Bioequivalence of GP30121 and Ceraxon® Corrected for Endogenous Analyte Level by A. N. Arevefa, A. R. Dorotenko, S. M. Noskov, I. E. Makarenko, R. V. Drai, T. N. Komarov, O. A. Archakova, N. S. Bagaeva, I. E. Shokhin

Get full text

Development of therapeutic peptide producers based on <i>Escherichia coli</i> BL21 and their cultivation technology by Z. R. Khasanshina, I. A. Kornakov, E. A. Buslaeva, A. V. Kazakova, S. A. Ishchuk, V. I. Shmurak, V. B. Saparova, V. F. Latypov, R. V. Drai

Get full text

Enzyme-Linked Immunosorbent Assay Method Application in the Study of Comparative Pharmacokinetics of Insulin Glargin Preparations by L. N. Shitov, Yu. A. Dzhurko, R. V. Drai, I. E. Makarenko, A. L. Khokhlov, L. A. Khozova, O. V. Afonkina, Yu. A. Sevastyanova, N. A. Vasilenko, A. A. Abramova

Get full text

Physiology, pharmacology and prospects for dipeptidilpeptidase-4 inhibitors use by D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, A. V. Strygin, Yu. V. Gorbunova, E. V. Volotova, I. E. Makarenko, V. B. Saparova, R. V. Drai, V. I. Petrov

Get full text

Dynamics of turnover of sugar-lowering drugs in the retail segment of the pharmaceutical market from 2020 to 2024 by D. V. Kurkin, E. V. Makarova, V. I. Zvereva, A. R. Makarova, D. A. Bakulin, O. V. Marincheva, Yu. V. Gorbunova, Yu. A. Kolosov, I. S. Krysanov, K. N. Koryanova, D. A. Galkina, N. A. Osadchenko, R. V. Drai, I. E. Makarenko, A. S. Shuvaeva

Get full text

Methodological and regulatory aspects of pharmaceutical development of biological products by D. V. Kurkin, E. I. Morkovin, D. A. Bakulin, A. V. Zaborovsky, I. E. Makarenko, R. V. Drai, A. G. Solodovnikov, V. I. Petrov, K. N. Koryanova, N. A. Lycheva, S. A. Voskresensky, A. V. Strygin, Yu. A. Kolosov, Yu. V. Gorbunova, O. V. Ivanova

Get full text

Overview of drugs approved by the FDA in 2022 by D. V. Kurkin, E. I. Morkovin, D. A. Bakulin, Yu. V. Gorbunova, Yu. A. Kolosov, M. A. Dzhavakhyan, I. E. Makarenko, R. V. Drai, A. V. Zaborovsky, O. V. Shatalova, A. V. Strygin, V. I. Petrov, A. P. Pleten, A. A. Prokopov, T. Yu. Tatarenko-Kozmina

Get full text

The first generic tirzepatide GP30931: physicochemical and biological similarity to the reference drug by I. A. Lugovik, A. V. Babina, S. S. Arutyunyan, D. О. Ermolaeva, V. B. Saparova, T. N. Kobeleva, P. G. Zaikin, A. D. Mikushina, A. S. Bukatin, I. E. Eliseev, B. Ts. Zajchik, Y. S. Keruchenko, I. S. Ohrimenko, E. V. Bocharov, A. Kh. Taldaev, V. A. Lushpa, I. E. Makarenko, R. V. Drai

Get full text

Original drugs approved by the Food and Drug Administration (Center for Drug Evaluation and Research) in 2024 by D. V. Kurkin, N. A. Osadchenko, A. R. Makarova, D. A. Galkina, D. A. Bakulin, O. V. Shatalova, A. V. Strygin, V. I. Petrov, O. V. Marincheva, Yu. V. Gorbunova, Yu. A. Kolosov, A. V. Zaborovsky, D. V. Yunina, K. N. Koryanova, E. I. Morkovin, M. A. Dzhavakhyan, V. I. Zvereva, R. V. Drai, I. E. Makarenko, A. S. Shuvaeva

Get full text